Seung-Hwan Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Seung-Hwan Lee has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Bhagavanth Reddy Gangapuram
Palamuru University
1 shared publicationGarima Sharma
Institute of Forest Science, Kangwon National University, Chuncheon 24341, Republic of Korea
1 shared publication- Jin-Chul Kim
Department of Biomedical Science & Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon, Korea
1 shared publication Jomon George Joy
Department of Biomedical Science and Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea
1 shared publication- Madhusudhan Alle
Department of Chemistry, The University of Memphis, Memphis, TN 38152, USA
1 shared publication Mydhili Govindarasu
Department of Biomedical Science and Institute of Bioscience and Biotechnology, Kangwon National University, Chuncheon 24341, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30
Cellulose Nanocrystal-Based Sulfatase-Responsive Hydrogel for Sustained Celecoxib Release in Ulcerative Colitis Therapy
Conventional treatments for ulcerative colitis (UC) are often associated with systemic side effects and require frequent dosing due to nonspecific drug distribution. Herein, a hydrogel based on poly(diallyldimethylammonium chloride) (PDADMAC) and cellulose nanocrystals (CNCs) was designed for the oral delivery of celecoxib in the treatment of UC. The hydrogel network incorporated sulfate ester groups, enabling sulfatase enzymes sensitive in the colon. Physiochemical characterization confirmed successful formation of the hydrogel, effective sulfate functionalization, and efficient drug encapsulation. Swelling studies revealed that the hydrogel maintained structural stability under different pH conditions, while in vitro and in vivo experiments demonstrated that drug release was markedly enhanced in the presence of sulfatase. Furthermore, the hydrogel showed improved drug loading efficiency and sustained release behavior. In a dextran sulfate sodium-induced UC mouse model, the celecoxib-loaded PDADMAC-CNC hydrogel effectively alleviated colonic inflammation, preserved colon structure, and reduced pro-inflammatory cytokine levels more markedly than free drug administration. This finding highlights the potential of sulfatase-responsive PDADMAC-CNC hydrogels as a targeted, safe, and effective approach for treating inflammatory bowel diseases, such as UC.
- 1 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Biomaterials Research
- Vol. 30
Open AccessCellulose Nanocrystal-Based Sulfatase-Responsive Hydrogel for Sustained Celecoxib Release in Ulcerative Colitis Therapy
Conventional treatments for ulcerative colitis (UC) are often associated with systemic side effects and require frequent dosing due to nonspecific drug distribution. Herein, a hydrogel based on poly(diallyldimethylammonium chloride) (PDADMAC) and cellulose nanocrystals (CNCs) was designed for the oral delivery of celecoxib in the treatment of UC. The hydrogel network incorporated sulfate ester groups, enabling sulfatase enzymes sensitive in the colon. Physiochemical characterization confirmed successful formation of the hydrogel, effective sulfate functionalization, and efficient drug encapsulation. Swelling studies revealed that the hydrogel maintained structural stability under different pH conditions, while in vitro and in vivo experiments demonstrated that drug release was markedly enhanced in the presence of sulfatase. Furthermore, the hydrogel showed improved drug loading efficiency and sustained release behavior. In a dextran sulfate sodium-induced UC mouse model, the celecoxib-loaded PDADMAC-CNC hydrogel effectively alleviated colonic inflammation, preserved colon structure, and reduced pro-inflammatory cytokine levels more markedly than free drug administration. This finding highlights the potential of sulfatase-responsive PDADMAC-CNC hydrogels as a targeted, safe, and effective approach for treating inflammatory bowel diseases, such as UC.
- 1 January 2021
- Published by Springer Nature
- p. 125-153
Graphene-Based Smart Nanomaterials for Photothermal Therapy
- 1 January 2021
- Published by Springer Nature
- p. 125-153
Graphene-Based Smart Nanomaterials for Photothermal Therapy